the diagnostic power of the platelet mass index for testicular tumours a simple blood test

• DOI: 10.5281/zenodo.5055899
• Publication Date: 2021-07-01
• Authors: Bulent Mersin Cit...; Ersan Bulut; Reha Girgin; Onder Cinar; Bulent Akduman; Gökhan Ceker
• Keywords: Medicine (General); pmi; PMI; Tumores testiculares; biomarkers; testicular tumours; 3. Good health; Testicular tumours; 03 medical and health sciences; Biomarcadores; R5-920; 0302 clinical medicine; Biomarkers

Introduction: The relationship between inflammation and cancer has long been the focus of researchers' interest. There are many inflammatory markers studied for this purpose in the literature. In this context, we focused on the effects of platelet counts and platelet mass index (PMI) as inflammatory markers in the diagnosis of low-volume localized testicular cancer. Materials and methods: Thirty-eight patients with localized testicular cancer with a mean age of 30.84 ± 5.79 years and 38 patients with varicocele as a control group with a mean age of 32.8 ± 9.7 years were enrolled in the study. Number of platelets, mean platelet volume and value of PMI were calculated from peripheral blood samples obtained. Results: Number of platelets and PMI values were statistically significantly higher in patients with testicular cancer compared with the control group (p<.05). Conclusions: Both platelet counts and PMI values can be used as a simple test in the diagnosis of testicular cancer besides the well-known accurate serum tumor markers as AFP (alpha fetoprotein), hCG (human chorionic gonadotropin) and LDH (lactate dehydrogenase).